Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

Taskinen, MR; Packard, CJ; Boren, J

Boren, J (reprint author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.; Boren, J (reprint author), Sahlgrens Univ Hosp, Gothenburg, Sweden.

CURRENT ATHEROSCLEROSIS REPORTS, 2019; 21 (8):

Abstract

Purpose of ReviewApolipoprotein C-III (apoC-III) is known to inhibit lipoprotein lipase (LPL) and function as an important regulator of triglyceride m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索